By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ranbaxy Pharmaceuticals Inc. 

600 College Road East

Princeton  New Jersey  08540  U.S.A.
Phone: 609-720-9200 Fax: 609-720-1155



Company News
Ranbaxy Pharmaceuticals Inc. Suspends Shipments From Two Plants 2/25/2014 7:28:00 AM
Ranbaxy Pharmaceuticals Inc. to Market Desvenlafaxine Base Extended Release Tablets in the U.S. 3/5/2013 10:54:34 AM
Ranbaxy Pharmaceuticals Inc. Launches Authorized Generic of Evoxac in the U.S. Healthcare Market 10/9/2012 10:23:16 AM
Ranbaxy Pharmaceuticals Inc. Drops Some Applications Filed With FDA 8/22/2012 7:21:36 AM
Ranbaxy Pharmaceuticals Inc. Launches Authorized Generic of Pioglitazone in the U.S. 8/17/2012 7:19:36 AM
Ranbaxy Pharmaceuticals Inc. Commends New IMS Study Which Credits Generic Prescription Drugs With $1 Trillion Savings In U.S. Health Care Costs Over Past 10 Years 8/3/2012 10:02:39 AM
6 Pharma Firms, Including Lupin Pharmaceuticals, Inc., Ranbaxy Pharmaceuticals Inc. and Dr. Reddy's Laboratories, Inc. (RDY) Ally to Improve Efficiency 1/12/2012 7:49:33 AM
Ranbaxy Pharmaceuticals Inc.'s Lipitor Copy Threatens Pfizer Inc. (PFE) Sales 12/1/2011 9:11:03 AM
Ranbaxy Pharmaceuticals Inc. Launches Donepezil 5 mg and 10 mg Tablets to U.S. Healthcare System 11/30/2010 7:40:10 AM
Study on Acne Suicide Risk Fuels Debate Over Isotretinoin, Made By Mylan Inc. (MYL), Ranbaxy Pharmaceuticals Inc. and Teva Pharmaceutical Industries Limited (TEVA); Severe Acne Increases Suicide Risk, Even With Successful Treatment 11/12/2010 6:38:53 AM